ICUI vs. ALGN, MMSI, HAE, XRAY, QDEL, NEOG, STAA, CERS, OSUR, and ANIK
Should you be buying ICU Medical stock or one of its competitors? The main competitors of ICU Medical include Align Technology (ALGN), Merit Medical Systems (MMSI), Haemonetics (HAE), DENTSPLY SIRONA (XRAY), QuidelOrtho (QDEL), Neogen (NEOG), STAAR Surgical (STAA), Cerus (CERS), OraSure Technologies (OSUR), and Anika Therapeutics (ANIK). These companies are all part of the "health care supplies" industry.
ICU Medical vs.
ICU Medical (NASDAQ:ICUI) and Align Technology (NASDAQ:ALGN) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, dividends, community ranking, valuation, profitability, risk, earnings, institutional ownership and media sentiment.
In the previous week, Align Technology had 15 more articles in the media than ICU Medical. MarketBeat recorded 21 mentions for Align Technology and 6 mentions for ICU Medical. ICU Medical's average media sentiment score of 1.19 beat Align Technology's score of 0.91 indicating that ICU Medical is being referred to more favorably in the media.
ICU Medical has a beta of 0.73, suggesting that its stock price is 27% less volatile than the S&P 500. Comparatively, Align Technology has a beta of 1.69, suggesting that its stock price is 69% more volatile than the S&P 500.
Align Technology has a net margin of 10.54% compared to ICU Medical's net margin of -4.74%. Align Technology's return on equity of 13.84% beat ICU Medical's return on equity.
Align Technology received 398 more outperform votes than ICU Medical when rated by MarketBeat users. Likewise, 69.84% of users gave Align Technology an outperform vote while only 64.27% of users gave ICU Medical an outperform vote.
Align Technology has higher revenue and earnings than ICU Medical. ICU Medical is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks.
96.1% of ICU Medical shares are owned by institutional investors. Comparatively, 88.4% of Align Technology shares are owned by institutional investors. 6.7% of ICU Medical shares are owned by insiders. Comparatively, 0.6% of Align Technology shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
ICU Medical presently has a consensus price target of $168.67, indicating a potential upside of 12.58%. Align Technology has a consensus price target of $266.73, indicating a potential upside of 56.56%. Given Align Technology's higher possible upside, analysts clearly believe Align Technology is more favorable than ICU Medical.
Summary
Align Technology beats ICU Medical on 14 of the 18 factors compared between the two stocks.
Get ICU Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for ICUI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
ICU Medical Competitors List
Related Companies and Tools
This page (NASDAQ:ICUI) was last updated on 3/25/2025 by MarketBeat.com Staff